Oppenheimer & Co’s EntrepreneurShares Series Trust ERShares Private-Public Crossover ETF XOVR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.06M Buy
49,855
+1,644
+3% +$33.4K 0.01% 890
2026
Q2
$1.01M Buy
48,211
+24,206
+101% +$462K 0.01% 920
2026
Q1
$405K Sell
24,005
-36,781
-61% -$669K ﹤0.01% 1277
2025
Q4
$1.22M Sell
60,786
-149
-0.2% -$3.06K 0.02% 719
2025
Q3
$1.29M Buy
60,935
+8,501
+16% +$170K 0.02% 774
2025
Q2
$1M Buy
52,434
+40,451
+338% +$695K 0.01% 853
2025
Q1
$191K Buy
+11,983
New +$215K ﹤0.01% 1465

Other funds holding XOVR

Oppenheimer & Co's XOVR Position: Q3 2026 in Review

Oppenheimer & Co increased its EntrepreneurShares Series Trust ERShares Private-Public Crossover ETF (XOVR) stake by 3.4% in Q3 2026, buying an estimated $33.4K and bringing the position to 49,855 shares worth $1.06M. The position accounts for 0.01% of the portfolio, ranked #890.

Oppenheimer & Co first reported a position in XOVR in Q1 2025 and has held it in 7 quarters since. The position peaked at $1.29M in Q3 2025. 73 funds tracked by Wall St. Rank hold XOVR as of Q3 2026.

  • Oppenheimer & Co held 49,855 shares of EntrepreneurShares Series Trust ERShares Private-Public Crossover ETF worth $1.06M as of Q3 2026.
  • Oppenheimer & Co bought 1,644 EntrepreneurShares Series Trust ERShares Private-Public Crossover ETF shares in Q3 2026, an estimated $33.4K.
  • EntrepreneurShares Series Trust ERShares Private-Public Crossover ETF made up 0.01% of Oppenheimer & Co's portfolio in Q3 2026, its #890 holding.
  • Oppenheimer & Co first reported a position in EntrepreneurShares Series Trust ERShares Private-Public Crossover ETF in Q1 2025 and has held it in 7 quarters since.
  • Oppenheimer & Co's EntrepreneurShares Series Trust ERShares Private-Public Crossover ETF position peaked at $1.29M in Q3 2025.
  • 73 funds tracked by Wall St. Rank held EntrepreneurShares Series Trust ERShares Private-Public Crossover ETF as of Q3 2026.

Based on Oppenheimer & Co's 13F filing for Q3 2026, filed 26 Oct 2026.